El viceministro de Salud Pública, Luis Suárez, indicó que el laboratorio Pfizer, el cual tiene un acuerdo con el Gobierno peruano, ha quedado en entregar un millón de vacunas contra el covid-19 cada mes, hasta completar cinco millones de dosis. (Fuente: américa TV) **Actualización: El noticiero de América Edición Sabatina interpretó mal al viceministro de Salud Pública Luis Suárez. Son 1,5 millones de vacunas contra el COVID-19 llegarán al país durante el primer trimestre del 2021 como parte de un contrato firmado con la farmacéutica Pfizer.
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/GEQ7WQKQH5AKHKPKX3Y6S7JWPI.png)
:quality(75)/dvgnzpfv30f28.cloudfront.net/11-01-2020/t_213044ff46de4d12b8a511d7f9460d00_name_file_640x360_600_v3_.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/Q5IHQ7WO6RGCHB35PGTKDFMWHQ.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/FQ5LW5P4LZHKLCXFJFBTPRMFZQ.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/UMwyZ3cT/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/s0C6EY3S/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/Fp4txKkv/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/0Iveihj3/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/WJ7ovIRU/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/t8AjJvjZ/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/ZJRMYQTLGVFTTCQZDWD6JUNJ34.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/XLIWX6IVYFA63APPYFLFMQREXI.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/OEOX64ECKFBR5H3UAOANUZ3Q2E.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/FQ5LW5P4LZHKLCXFJFBTPRMFZQ.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/UMwyZ3cT/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/frIfgMIX/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/Lc0ZrqXX/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/GEQ7WQKQH5AKHKPKX3Y6S7JWPI.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/Q5IHQ7WO6RGCHB35PGTKDFMWHQ.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/ZOUZQFL2UZEO5LWZUPKIPD7LHQ.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/VNBRMI43GNDOPLZ5YTIZLUGJUE.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/koNs9MA2/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/6bLTGi5d/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/KgeU8b6Q/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/a6mwPQ4X/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/X3PAJUVAAFHRXHUYV5TON7UAAY.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/wXUo9jVU/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/nu9nKgwG/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/GCHGHNUMHVAIDBFA2VHOVRIAMY.png)
:quality(75)/cdn.jwplayer.com/v2/media/c0S03whF/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/azLadx4o/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/FQ5XSTUGQ5DI3DYDC3MUSLQL6A.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/9a1H4G0a/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/Xv8iJGpA/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/EXTCEP2GUBC7XBDWQE34RG4BO4.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/DOIUFLVUQ5AJDN2ZVTQQC7KHZ4.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/dXst1BW1/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/JW2JBE7IBZEY5NR2VH4KVTPGZ4.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/42WZKDIDGVA6VKQDF75376W2CA.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/ENCJ6JEIFZHT5E6UXK3KZ5RCUU.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/UZ27WLDNBFBCPCMLG42DQCNJYA.png)